Fosun Technology Innovation Center

Fosun Technology Innovation Center is the strategic research and development and innovation management arm of the Fosun Group, primarily focused on the healthcare and life sciences sectors. The center oversees a global network of over 20 innovation hubs, including major facilities in Shanghai, Suzhou, and the United States, and is responsible for the group's "in-depth incubation" and "license-in" strategies. It drives the development of a diverse pipeline of innovative drugs and biosimilars through its core platforms, such as Fosun Pharma and Henlius, with a strong emphasis on oncology, immunology, and cell therapy. Notable achievements include the development and commercialization of world-first therapies in the PD-1 and CAR-T spaces. By integrating global resources and cutting-edge technology platforms, the center aims to address unmet clinical needs and accelerate the translation of scientific breakthroughs into localized medical products.